BSE Live
Dec 26, 16:01Prev. Close
424.45
Open Price
422.25
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 26, 15:59Prev. Close
422.00
Open Price
420.05
Bid Price (Qty.)
419.15 (22)
Offer Price (Qty.)
419.50 (49)
| Key Financial Ratios of Aarti Drugs (in Rs. Cr.) | Mar 15 | Mar 12 | Mar 10 | Mar 09 | Mar 08 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 31.90 | 18.63 | 23.26 | 13.63 | 11.73 | |
| Diluted EPS (Rs.) | 31.90 | 18.63 | 23.26 | 13.63 | 11.73 | |
| Cash EPS (Rs.) | 44.71 | 36.01 | 37.48 | 27.23 | 24.62 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 127.25 | 146.85 | 124.96 | 113.34 | 107.71 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 127.25 | 146.85 | 124.96 | 113.34 | 107.71 | |
| Revenue from Operations/Share (Rs.) | 452.94 | 549.42 | 395.25 | 326.64 | 266.78 | |
| PBDIT/Share (Rs.) | 70.06 | 64.53 | 66.88 | 55.22 | 37.22 | |
| PBIT/Share (Rs.) | 57.25 | 46.36 | 52.81 | 42.86 | 26.09 | |
| PBT/Share (Rs.) | 41.18 | 26.68 | 39.11 | 22.11 | 17.06 | |
| Net Profit/Share (Rs.) | 31.90 | 17.84 | 23.41 | 14.84 | 12.55 | |
| NP After MI And SOA / Share (Rs.) | 31.90 | 17.91 | 23.26 | 13.63 | 11.73 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 15.46 | 11.74 | 16.92 | 16.90 | 13.95 | |
| PBIT Margin (%) | 12.64 | 8.43 | 13.36 | 13.12 | 9.78 | |
| PBT Margin (%) | 9.09 | 4.85 | 9.89 | 6.76 | 6.39 | |
| Net Profit Margin (%) | 7.04 | 3.24 | 5.92 | 4.54 | 4.70 | |
| NP After MI And SOA Margin (%) | 7.04 | 3.25 | 5.88 | 4.17 | 4.39 | |
| Return on Networth/Equity (%) | 25.07 | 12.19 | 19.23 | 12.94 | 12.31 | |
| Return on Capital Employed (%) | 26.70 | 20.21 | 7.79 | 4.64 | 3.82 | |
| Return on Assets (%) | 7.71 | 3.67 | 6.71 | 3.95 | 3.29 | |
| Total Debt/Equity (X) | 1.35 | 1.53 | 1.29 | 1.56 | 1.95 | |
| Asset Turnover Ratio (%) | 109.47 | 0.00 | 114.18 | 94.84 | 74.97 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 1.09 | 0.97 | 3.55 | 3.28 | 3.46 | |
| Quick Ratio (X) | 0.75 | 0.66 | 2.44 | 2.27 | 2.31 | |
| Inventory Turnover Ratio (X) | 6.68 | 0.00 | 7.43 | 6.32 | 4.72 | |
| Dividend Payout Ratio (NP) (%) | 0.00 | 0.00 | 21.49 | 22.01 | 15.34 | |
| Dividend Payout Ratio (CP) (%) | 0.00 | 0.00 | 13.39 | 11.52 | 7.56 | |
| Earnings Retention Ratio (%) | 0.00 | 0.00 | 78.51 | 77.99 | 84.66 | |
| Cash Earnings Retention Ratio (%) | 0.00 | 0.00 | 86.61 | 88.48 | 92.44 | |
| Coverage Ratios | ||||||
| Interest Coverage Ratios (%) | 3.56 | 3.45 | 3.85 | 2.07 | 2.89 | |
| Interest Coverage Ratios (Post Tax) (%) | 3.56 | 3.45 | 3.85 | 2.07 | 2.89 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 1,990.67 | 390.57 | 308.86 | 242.69 | 289.12 | |
| EV/Net Operating Revenue (X) | 1.81 | 0.59 | 0.65 | 0.63 | 0.93 | |
| EV/EBITDA (X) | 11.73 | 5.00 | 3.81 | 3.75 | 6.63 | |
| MarketCap/Net Operating Revenue (X) | 1.44 | 0.19 | 0.26 | 0.12 | 0.20 | |
| Retention Ratios (%) | 0.00 | 0.00 | 78.50 | 77.98 | 84.65 | |
| Price/BV (X) | 5.12 | 0.69 | 0.84 | 0.36 | 0.55 | |
| Price/Net Operating Revenue | 1.44 | 0.19 | 0.26 | 0.12 | 0.20 | |
| Earnings Yield | 0.05 | 0.18 | 0.23 | 0.36 | 0.22 |
14.11.2025
Aarti Drugs Consolidated September 2025 Net Sales at Rs 652.79 crore, up 9.1% Y-o-Y
12.11.2025
Aarti Drugs Standalone September 2025 Net Sales at Rs 578.95 crore, up 6.6% Y-o-Y
18.07.2025
Aarti Drugs Standalone June 2025 Net Sales at Rs 520.96 crore, up 5.68% Y-o-Y
18.07.2025
Aarti Drugs Consolidated June 2025 Net Sales at Rs 590.51 crore, up 6.33% Y-o-Y